Supplemental information for PAR-16-357
Office of the Director
Program Announcements
- NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
- NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
- Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)
- NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
- Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)
Request for Applications
Notices of Special Interest (NOSI)
- Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience - R01,R21
- Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research - R01,R21,R03
- Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain - R01,R03,R21
Notices
Chemistry Pharmacology Branch
Program Announcements
- Discovery of in vivo Chemical Probes for Novel Brain Targets (R01)
- Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
- Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
- Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
- BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)
- BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed)
- Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
- Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Notices
Genetics, Epigenetics and Development Branch
Program Announcements
- Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed)
- Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
- Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)
- Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)
- Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)
- NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
- Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)
- Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed)
- AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
- Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
- Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
- Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)
- Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)
Request for Applications
Notices of Special Interest (NOSI)
- Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supp) - 333
- Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) - R01,R21
Notices
Behavioral Cognitive Neuroscience Branch
Program Announcements
- Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional)
- Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
- Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional )
- Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
- Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
- Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
- Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
- Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)
- Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
- Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)
Request for Applications
- The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
- Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)
- Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
- Tobacco Regulatory Science (R01 Clinical Trial Optional)
Notices of Special Interest (NOSI)
Notices
- Notice of Additional Funds Available for PAS-18-625, " Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)"
- Notice of Additional Funds Available for PAS-18-624, " Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)"
Integrative Neuroscience Branch
Program Announcements
- Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed)
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- HIV-1 infection of the Central Nervous System (R01)
- Imaging the Persistent HIV Reservoir (R01)
- Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)
- Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)
Notices of Special Interest (NOSI)
Notices
- Notice of Change to the Eligibility of Foreign Components in PA-18-060, " Neuroscience Research on Drug Abuse (R01)"
- Notice of Change to the Eligibility of Foreign Components in PA-18-078, " Neuroscience Research on Drug Abuse (R21)"
- Notice of Change to the Open Date in PA-18-917, " Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
- BRAIN Initiative: Notice of Support for Research on the Fundamental Neurobiology of Endogenous Opioid Systems